Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2025-12-26 @ 3:57 AM
Study NCT ID:
NCT05592418
Status:
COMPLETED
Last Update Posted:
2025-01-22
First Post:
2022-10-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
Sponsor:
AIM ImmunoTech Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-20
First Submit QC Date:
None
Study First Post Date:
2022-10-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-17
Results First Submit QC Date:
None
Results First Post Date:
2025-01-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-31
Last Update Post Date:
2025-01-22
Last Update Post Date Type:
ACTUAL